High-throughput virtual screening and preclinical analysis identifies CB-1, a novel potent dual B-Raf/c-Raf inhibitor, effective against wild and mutant variants of B-Raf expression in colorectal carcinoma. - Mesfer Al Shahrani; Mohammad Abohassan; Mohammad Y. Alshahrani; Abdulrahim R. Hakami; Prasanna Rajagopalan (J. Comput. Aided Mol. Des., 2021)